Skip to main content

Nashville Biosciences Archives

The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK and Novo Nordisk

Jan. 5, 2024—Bristol Myers Squibb, GSK and Novo Nordisk are the newest members of the Alliance for Genomic Discovery.

Read more


Landmark academic-industry partnership harvests human genome “fruits” for research

Nov. 14, 2023—The first fruits of a landmark academic-industry partnership that is harvesting the depth and breadth of the human genome to better understand and treat disease will become available to researchers in the spring of 2024.

Read more


New “DNA” podcast season explores how to harness change, ideas to improve business and medicine

Oct. 2, 2023—Go to your favorite podcast channel right now to subscribe and listen to the first episode of Season 4!

Read more


The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Jul. 18, 2023—Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

Read more


Alliance for Genomic Discovery FAQs

Jul. 18, 2023—Here are frequently asked questions about Vanderbilt University Medical Center's Alliance for Genomic Discovery.

Read more


Nashville Biosciences and Illumina announce sequencing agreement with Amgen

Jan. 9, 2023—Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.

Read more


Nashville Biosciences and Illumina announce agreement to establish preeminent clinico-genomic resource for life sciences research & development

Jan. 10, 2022—Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center, has announced an agreement with Illumina, a leading genomic technology company, to realize the full potential of VUMC’s DNA databank, BioVU.

Read more


Nashville Biosciences created to leverage wealth of data

Apr. 5, 2018—Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more